Ads
related to: what drugs stimulate platelet production in the brain and carry insulin- Treating With TAVALISSE
Learn More from Dr. Craig Kessler
Regarding the Novel Way To Treat
- Resource Library
Download A Variety Of Clinical
Resources For You & Your Patients
- Patient Cases
Review Patient Cases To See How
TAVALISSE May Work For Your Patient
- Explore Efficacy Data
See How This Therapy Helped Drive
Improvements In Platelet Counts
- Treating With TAVALISSE
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Thrombopoietin is a glycoprotein hormone produced by the liver and kidney which regulates the production of platelets. It stimulates the production and differentiation of megakaryocytes, the bone marrow cells that bud off large numbers of platelets. [5] Megakaryocytopoiesis is the cellular development process that leads to platelet production.
Thrombopoietin mimetics are drugs that considerably increase platelet production by stimulating the receptor for the hormone thrombopoietin; Romiplostim and Eltrombopag are examples. [1] Thrombopoietin mimetics are a type of thrombopoietic agents. There has been a development of a registry of pregnant patients that were treated with these drugs ...
Romiplostim, sold under the brand name Nplate among others, is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.. The most common side effects in adults include headache, infections of the nose and throat, and allergic (hypersensitivity) reactions such as rash, itching and rapid swelling under the skin. [1]
Oprelvekin is recombinant interleukin eleven (IL-11), [1] a thrombopoietic growth factor that directly stimulates the proliferation of hematopoietic stem cells and megakaryocyte progenitor cells and induces megakaryocyte maturation resulting in increased platelet production.
Platelet aggregation plays a critical role in the genesis of a resulting thrombus. Adhesion should remain local, but platelet aggregation must grow exponentially to form a platelet thrombus and prevent blood loss. Platelet aggregation factors are the regulators that enhance the adhesion and stimulate the platelets to secrete its granules.
Newer NSAID drugs called COX-2 selective inhibitors have been developed that inhibit only COX-2, with the hope for reduction of gastrointestinal side-effects. [8] However, several COX-2 selective inhibitors have subsequently been withdrawn after evidence emerged that COX-2 inhibitors increase the risk of heart attack. [ 9 ]
Ad
related to: what drugs stimulate platelet production in the brain and carry insulin